Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Project
Understanding the role of nuclear receptor HNF4a in sepsis and unravel the mechanisms of its loss-of-function in relation to PPARa failure.
Information
Project Team
Organisations
Outputs & Impact
Publications & research data ( 5 )
A crucial role of the malate aspartate shuttle in metabolic reprogramming in TNF-induced SIRS
Louise Nuyttens
Marah Heyerick
Maxime Roes
Elise Moens
Céline Van Dender
Charlotte Wallaeys
Tino Hochepied
Steven Timmermans
Jolien Vandewalle
Claude Libert
U
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2025
HNF4α contributes to hepatic CAR dysfunction in polymicrobial sepsis
Céline Van Dender
Steven Timmermans
Maxime Roes
Madeleine Hellemans
Elise Moens
Louise Nuyttens
Maarten Claes
Bart Roman
Karolien De Bosscher
Jolien Vandewalle
et al.
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2025
Unraveling mitochondrial pyruvate dysfunction to mitigate hyperlactatemia and lethality in sepsis
Louise Nuyttens
Marah Heyerick
Geike Heremans
Elise Moens
Maxime Roes
Céline Van Dender
Liesbet De Bus
Johan Decruyenaere
Jan De Waele
Jolien Vandewalle
et al.
A1
Journal Article
in
CELL REPORTS
2025
Balancing metabolism and regeneration in liver diseases through HNF4α targeting
Céline Van Dender
Jolien Vandewalle
Claude Libert
A1
Journal Article
in
TRENDS IN ENDOCRINOLOGY AND METABOLISM
2025
A critical role for HNF4α in polymicrobial sepsis-associated metabolic reprogramming and death
Céline Van Dender
Steven Timmermans
Ville Paakinaho
Tineke Vanderhaeghen
Jolien Vandewalle
Maarten Claes
Bruno Garcia
Bart Roman
Jan De Waele
Siska Croubels
et al.
A1
Journal Article
in
EMBO MOLECULAR MEDICINE
2024
Activities ( 0 )
Results
Impact narratives ( 0 )
Patents ( 0 )